IL-12A和EBI3在OSCC中的表达及其与免疫微环境的关系

doi:10.13701/j.cnki.kqyxyj.2022.06.010

口腔医学研究 ›› 2022, Vol. 38 ›› Issue (6): 533-539.DOI: 10.13701/j.cnki.kqyxyj.2022.06.010

IL-12A和EBI3在OSCC中的表达及其与免疫微环境的关系

吕宜楠^1,2, 胡雅英^1,2, 郑小风^1,2, 杨可^1,2, 张佳莉^1,2*

1.武汉大学口腔医院口腔病理科湖北武汉 430079;
2.口腔基础医学省部共建国家重点实验室培育基地和口腔生物医学教育部重点实验室武汉大学口腔医学院湖北武汉 430079

收稿日期:2021-08-26 出版日期:2022-06-28 发布日期:2022-06-23
通讯作者: * 张佳莉,E-mail: jiali_zhang@whu.edu.cn
作者简介:吕宜楠(1996~),女,浙江金华人,硕士在读,主要从事口腔肿瘤的研究。
基金资助:
国家自然科学基金(编号:81972552)

Expression of IL-12A and EBI3 in Oral Squamous Cell Carcinoma and Their Effect on Immune Microenvironment

LV Yinan^1,2, HU Yaying^1,2, ZHENG Xiaofeng^1,2, YANG Ke^1,2, ZHANG Jiali^1,2*

1. Department of Oral Histopathology, Hospital of Stomatology, Wuhan University, Wuhan 430079, China;
2. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei _MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School of Stomatology, Wuhan University, Wuhan 430079, China

Received:2021-08-26 Online:2022-06-28 Published:2022-06-23

摘要/Abstract

摘要： 目的:探讨IL-35两个亚基IL-12A和EBI3在口腔鳞状细胞癌(OSCC)组织中的表达,及其与OSCC患者临床病理特征、预后和免疫微环境的关系。方法:通过组织芯片和免疫组织化学法检测186例OSCC患者的正常组织及癌组织中的IL-35亚基IL-12A和EBI3的表达水平,中性粒细胞和CD4⁺T细胞的浸润水平;通过TCGA数据库和TIMER数据库分析IL-12A和EBI3与OSCC无病间期和免疫细胞浸润的关系。结果:IL-12A和EBI3在肿瘤组织中表达显著高于正常上皮(P＜0.001)。IL-12A和EBI3在肿瘤组织中的表达具有相关性(r=0.45,P<0.01),IL-12A和EBI3的表达水平只与OSCC的病理分级有关。IL-12A和EBI3低表达患者的预后更佳(P<0.05),无病间期也更长(P<0.05)。免疫浸润分析发现EBI3和中性粒细胞浸润相关(r=0.311,P<0.0001),IL12A与CD4⁺T细胞有关(r=0.254,P<0.05)。结论:IL-35亚基IL-12A和EBI3在OSCC中表达上升,影响OSCC患者的预后并影响免疫相关细胞浸润水平。

关键词: 白细胞介素-35, 口腔鳞状细胞癌, 预后, 肿瘤微环境

Abstract: Objective: To investigate the expression of IL-35 subunits IL12A and EBI3 in oral squamous cell carcinoma(OSCC) and theirs relationship with clinicopathological features, prognosis, and immune microenvironment. Methods: The expression levels of IL-35 subunits IL-12A and EBI3, and neutrophil and CD4⁺T cell infiltration in normal and cancer tissues of 186 OSCC patients were detected by tissue microarray and immunohistochemistry. TCGA database and TIMER database were used to analyze the relationship between IL-12A and EBI3 and disease-free interval time and immune cell infiltration of OSCC. Results: The expression of IL-12A and EBI3 in tumor tissue was significantly higher than that in normal epithelium (P<0.001). The expression levels of IL-12A and EBI3 were correlated in tumor tissues (r=0.45, P<0.01). Kaplan-Meier survival analysis showed that patients with low expression of IL-12A and EBI3 had better prognosis (P<0.05) and longer disease-free interval time (P<0.05). IL-12A was associated with CD4⁺T infiltration (r=0.254, P<0.05). EBI3 was associated with neutropil infiltration(r=0.311, P<0.0001), respectively. Conclusion: The increased expression of IL-35 subunits IL-12A and EBI3 in OSCC can affect the prognosis of OSCC patients and the level of immune related cell infiltration.

Key words: IL-35, OSCC, prognosis, TME

吕宜楠, 胡雅英, 郑小风, 杨可, 张佳莉. IL-12A和EBI3在OSCC中的表达及其与免疫微环境的关系[J]. 口腔医学研究, 2022, 38(6): 533-539.

LV Yinan, HU Yaying, ZHENG Xiaofeng, YANG Ke, ZHANG Jiali. Expression of IL-12A and EBI3 in Oral Squamous Cell Carcinoma and Their Effect on Immune Microenvironment[J]. Journal of Oral Science Research, 2022, 38(6): 533-539.

参考文献

[1] 曹雨庵,郭伟.我国口腔鳞癌的治疗现状[J].实用肿瘤杂志,2012,27(2):109-112.
[2] 陈新,徐文健,周健,等.口腔鳞状细胞癌现状[J].口腔医学,2017,37(5):462-465.
[3] 胡雅英,陈文,张佳莉.IGF2BP2的异常表达影响OSCC的增殖和侵袭[J].口腔医学研究,2021,37(4): 354-359.
[4] Pylayeva-Gupta Y. Molecular pathways: Interleukin-35 in autoimmunity and cancer [J]. Clin Cancer Res, 2016, 22(20): 4973-4978.
[5] Huang C, Li N, Li Z, et al. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression [J]. Nat Commun, 2017, 8: 14035.
[6] Li T, Fan J, Wang B, et al. Timer: A web server for comprehensive analysis of tumor-infiltrating immune cells [J]. Cancer Res, 2017, 77(21): e108-e110.
[7] Weckx A, Riekert M, Grandoch A, et al. Time to recurrence and patient survival in recurrent oral squamous cell carcinoma [J]. Oral Oncol, 2019, 94: 8-13.
[8] Dourado MR, Korvala J, Åström P, et al. Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma [J]. J Extracell Vesicles, 2019, 8(1): 1578525.
[9] Teymouri M, Pirro M, Fallarino F, et al. IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases [J]. Int J Cancer, 2018, 143(9): 2105-2115.
[10] Tao Q, Pan Y, Wang Y, et al. Regulatory T cells-derived IL-35 promotes the growth of adult acute myeloid leukemia blasts [J]. Int J Cancer, 2015, 137(10): 2384-2393.
[11] Zhang T, Nie J, Liu X, et al. Correlation analysis among the level of IL-35, microvessel density, lymphatic vessel density, and prognosis in non-small cell lung cancer [J]. Clin Transl Sci, 2021, 14(1): 389-394.
[12] Nicholl MB, Ledgewood CL, Chen X, et al. IL-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: evidence for a role as an autocrine growth factor [J]. Cytokine, 2014, 70(2): 126-133.
[13] Huang C, Li Z, Li N, et al. Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice [J]. Gastroenterology, 2018, 154(3): 675-688.
[14] Javvadi LR, Parachuru VPB, Milne TJ, et al. Expression of IL33 and IL35 in oral lichen planus [J]. Arch Dermatol Res, 2018, 310(5): 431-441.
[15] Kim HJ, Cantor H. CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful [J]. Cancer Immunol Res, 2014, 2(2): 91-98.
[16] Hao S, Chen X, Wang F, et al. Breast cancer cell-derived IL-35 promotes tumor progression via induction of IL-35-producing induced regulatory T cells [J]. Carcinogenesis, 2018, 39(12): 1488-1496.
[17] Zou JM, Qin J, Li YC, et al. IL-35 induces N2 phenotype of neutrophils to promote tumor growth [J]. Oncotarget, 2017, 8(20): 33501-33514.

IL-12A和EBI3在OSCC中的表达及其与免疫微环境的关系

Expression of IL-12A and EBI3 in Oral Squamous Cell Carcinoma and Their Effect on Immune Microenvironment

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	彭艳霜, 刘英. Sox基因在口腔鳞状细胞癌中作用及机制的研究进展[J]. 口腔医学研究, 2022, 38(4): 312-315.
[2]	胡勤刚, 泥艳红, 王雨晗. 代谢组学在口腔鳞状细胞癌早期诊断及精准诊疗中的研究进展[J]. 口腔医学研究, 2022, 38(3): 207-211.
[3]	齐元莉, 闫红娟, 祖木热提古丽·阿不来提, 张超杰, 赵举红, 徐江. 口腔鳞状细胞癌中CASZ1的表达及临床意义[J]. 口腔医学研究, 2022, 38(1): 30-33.
[4]	李杨, 李雯, 陈茁, 李帅泽, 乔彬. 口腔鳞状细胞癌患者循环肿瘤细胞上皮-间充质转化状态的研究[J]. 口腔医学研究, 2022, 38(1): 34-38.
[5]	林晶, 金成日, 玄云泽. β-Lapachone通过诱导ROS生成调控口腔鳞状细胞癌增殖与凋亡的机制研究[J]. 口腔医学研究, 2022, 38(1): 39-44.
[6]	周伟, 汤雅, 李厚轩, 陈斌, 闫福华. 牙周牙髓联合病变患牙预后观察的回顾性研究[J]. 口腔医学研究, 2021, 37(9): 825-829.
[7]	王译雪, 徐颖婕, 丛蓓蓓, 魏昕. 淫羊藿素调控Ki-67及Notch-1基因表达对人口腔鳞状细胞癌细胞的促凋亡效应研究[J]. 口腔医学研究, 2021, 37(6): 505-508.
[8]	李磊, 陈彦平, 杨凯成, 李悠, 王欣晨, 罗风玉. 基于GEO数据库分析AKR1C3在口腔鳞状细胞癌中的表达[J]. 口腔医学研究, 2021, 37(6): 514-518.
[9]	胡雅英, 陈文, 张佳莉. IGF2BP2的异常表达影响口腔鳞状细胞癌的增殖和侵袭[J]. 口腔医学研究, 2021, 37(4): 354-359.
[10]	张旭, 刘佳文. MMP-9、COX-2、NF-κB在口腔鳞状细胞癌组织中的表达及意义[J]. 口腔医学研究, 2021, 37(4): 360-365.
[11]	尹芳, 李进杰, 龚平, 周腾鹏, 刘可斌, 张铁军. 两种全麻方法对口腔鳞癌患者免疫功能影响的比较研究[J]. 口腔医学研究, 2021, 37(2): 153-156.
[12]	刘阳, 张昊, 余伟, 胡图强, 汤伟伟. 大黄素对口腔鳞状细胞癌增殖、侵袭和迁移的影响[J]. 口腔医学研究, 2021, 37(11): 1042-1047.
[13]	高安天, 林梓桐. 口腔鳞状细胞癌边界精准评价的光学成像研究进展[J]. 口腔医学研究, 2020, 36(5): 413-415.
[14]	杨凯成, 杨蕾, 赵建广, 罗风玉, 陈彦平, 崔子峰, 陈赫, 满莎莎. 口腔鳞状细胞癌患者外周血microRNA的表达及预后意义[J]. 口腔医学研究, 2020, 36(5): 428-432.
[15]	孙振龙, 薛鹏, 遆云飞. 牙根发育完成自体牙移植远期预后及影响因素分析[J]. 口腔医学研究, 2020, 36(5): 449-453.